Cargando…

Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid

In this study, we have characterized the role of annexin A1 (ANXA1) in the acquisition and maintenance of stem-like/aggressive features in prostate cancer (PCa) cells comparing zoledronic acid (ZA)-resistant DU145R80 with their parental DU145 cells. ANXA1 is over-expressed in DU145R80 cells and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bizzarro, Valentina, Belvedere, Raffaella, Milone, Maria Rita, Pucci, Biagio, Lombardi, Rita, Bruzzese, Francesca, Popolo, Ada, Parente, Luca, Budillon, Alfredo, Petrella, Antonello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694816/ https://www.ncbi.nlm.nih.gov/pubmed/26312765

Ejemplares similares

Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells
por: Belvedere, Raffaella, et al.
Publicado: (2014)

Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors
por: Bizzarro, Valentina, et al.
Publicado: (2012)

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype
por: Milone, Maria Rita, et al.
Publicado: (2014)

Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway
por: Belvedere, Raffaella, et al.
Publicado: (2016)

miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing
por: Belvedere, Raffaella, et al.
Publicado: (2018)

Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions
por: Bizzarro, Valentina, et al.
Publicado: (2012)

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
por: Milone, M R, et al.
Publicado: (2013)

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
por: Milone, M R, et al.
Publicado: (2014)

The Pharmaceutical Device Prisma(®) Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound Healing
por: Belvedere, Raffaella, et al.
Publicado: (2017)

Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs
por: Pessolano, Emanuela, et al.
Publicado: (2019)

Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System
por: Pessolano, Emanuela, et al.
Publicado: (2018)

Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity
por: Pecoraro, Michela, et al.
Publicado: (2023)

Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity
por: Novizio, Nunzia, et al.
Publicado: (2022)

Mesoglycan connects Syndecan‐4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro
por: Pessolano, Emanuela, et al.
Publicado: (2021)

TFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism
por: Romano, Elena, et al.
Publicado: (2018)

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
por: Bruzzese, F, et al.
Publicado: (2013)

Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors
por: Novizio, Nunzia, et al.
Publicado: (2020)

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
por: Lombardi, Rita, et al.
Publicado: (2021)

Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
por: Iannelli, Federica, et al.
Publicado: (2020)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
por: Grumetti, Laura, et al.
Publicado: (2022)

The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk
por: Belvedere, Raffaella, et al.
Publicado: (2022)

The Protecting Activity of RIPACUT(®): A New Therapeutic Approach Preserving Epithelial Health Based on the Combination of Iceland Lichen Extract, Silver Salt, and Sodium Hyaluronate
por: Belvedere, Raffaella, et al.
Publicado: (2023)

Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative
por: Morretta, Elva, et al.
Publicado: (2023)

The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EVs
por: Belvedere, Raffaella, et al.
Publicado: (2021)

PCL/Mesoglycan Devices Obtained by Supercritical Foaming and Impregnation
por: Franco, Paola, et al.
Publicado: (2019)

Supercritical Impregnation of Mesoglycan and Lactoferrin on Polyurethane Electrospun Fibers for Wound Healing Applications
por: Mottola, Stefania, et al.
Publicado: (2023)

ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progression and Metastasis
por: Novizio, Nunzia, et al.
Publicado: (2021)

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
por: Ciardiello, Chiara, et al.
Publicado: (2019)

The Procoagulant Activity of Emoxilane(®): A New Appealing Therapeutic Use in Epistaxis of the Combination of Sodium Hyaluronate, Silver Salt, α-tocopherol and D-panthenol
por: Belvedere, Raffaella, et al.
Publicado: (2021)

Production of Mesoglycan/PCL Based Composites through Supercritical Impregnation
por: Liparoti, Sara, et al.
Publicado: (2022)

Serials: acquisition and maintenance
por: Brown, Clara D
Publicado: (1975)

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
por: Fazzi, Rita, et al.
Publicado: (2021)

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
por: Iannelli, Federica, et al.
Publicado: (2020)

The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells
por: Colangelo, T, et al.
Publicado: (2016)

A DR/NIR Hybrid Polymeric Tool for Functional Bio-Coatings: Theoretical Study, Cytotoxicity, and Antimicrobial Activity
por: Diana, Rosita, et al.
Publicado: (2023)

Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma
por: Zhang, Xialu, et al.
Publicado: (2023)

Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid
por: Ferraro, Giusy, et al.
Publicado: (2022)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
por: Cocco, Stefania, et al.
Publicado: (2022)

AnnexinA7 promotes epithelial–mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma
por: Ling, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umc6sjnrdlntdl1p57kt4cguak